Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial
Official title:
Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder
To observe the clinical efficacy and mechanism of functional near-infrared spectroscopy imaging neurofeedback therapy for attention deficit and hyperactivity disorder.
In this study, a parallel controlled study will be conducted to recruit 60 patients with ADHD, 30 patients in the fNIRS group and 30 patients in the drug group. At the same time, 30 healthy controls will be recruited. 6 weeks, 12 sessions of NIRS feedback will be given for participants in NIRS group and healthy controls. 6 weeks of first or second line medication will be given for participants of drug group. Magnetic resonance imaging will be performed at baseline for all participants. SNAP IV, PSQ, CGI will be evaluated at baseline, week 3, week 6 and week 8 for ADHD participants. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03260205 -
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
| Withdrawn |
NCT03546400 -
Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
| Completed |
NCT02917109 -
LearningRx Cognitive Training for ADHD
|
N/A | |
| Completed |
NCT02248948 -
Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children
|
N/A | |
| Recruiting |
NCT01750307 -
The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment)
|
N/A | |
| Recruiting |
NCT06170996 -
Internet-Assisted Behavioral Parent Training Intervention for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
| Completed |
NCT00735371 -
Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
| Withdrawn |
NCT03580005 -
A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
| Completed |
NCT02578030 -
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
|
Phase 1 | |
| Completed |
NCT02574273 -
Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)
|
N/A | |
| Completed |
NCT02257216 -
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
| Recruiting |
NCT04943796 -
A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
|
||
| Recruiting |
NCT04634006 -
Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study
|
N/A | |
| Active, not recruiting |
NCT02908802 -
Probiotic Supplement as Treatment for Students With ADHD
|
N/A | |
| Completed |
NCT02604407 -
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
|
Phase 3 | |
| Completed |
NCT05870605 -
Drug Use Study With Intuniv® in European Countries
|
||
| Terminated |
NCT03481959 -
Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
|
Phase 3 | |
| Terminated |
NCT03638466 -
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder
|
Phase 2 | |
| Completed |
NCT03709940 -
Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
| Completed |
NCT02795637 -
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
|
Phase 1 |